[Screening for malignant neoplasms by using the new method of marker diagnosis, the Oncotest].
The proposed method for tumor screening ("Oncotest") is based on detecting substances (calcium-histone complexes) in the human blood which are markers of malignant neoplasia. Using "Oncotest" in a series of 5411 cases, we identified malignant tumors of various histogenesis (cancer, sarcoma) arising in different sites in 69 cases. "Oncotest" is especially important for early (pre-clinical) detection of malignant neoplasms during preventive population screenings.
Suslov
E I
EI
Galakhin
K A
KA
Vladimirov
V A
VA
Morozov
A A
AA
Vishnevskiĭ
V V
VV
D014408:Biomarkers, Tumor / Q000097:blood*; D002118:Calcium / Q000097:blood*; D003951:Diagnostic Errors; D004781:Environmental Exposure / Q000009:adverse effects; D005069:Evaluation Studies as Topic; D006657:Histones / Q000097:blood*; D006801:Humans; D008403:Mass Screening / Q000379:methods* / Q000706:statistics & numerical data; D009369:Neoplasms / Q000175:diagnosis / Q000517:prevention & control*; D009381:Neoplasms, Radiation-Induced / Q000175:diagnosis / Q000517:prevention & control; D009784:Occupational Diseases / Q000175:diagnosis / Q000517:prevention & control; D011210:Power Plants; D018788:Radioactive Hazard Release; D014455:Ukraine
D014408:Biomarkers, Tumor; D006657:Histones; D002118:Calcium